ARX:ASX
Aroa Biosurgery Ltd
A$0.48
arrow_downward
-1.02%(-0.0050) 1D
Nov 20, 4:10:08 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.50
High
A$0.50
Low
A$0.48
Mkt. cap
167.76M
Avg. vol.
259.42K
Volume
192.34K
P/E ratio
46.19
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.50
High
A$0.50
Low
A$0.48
Mkt. cap
167.76M
Avg. vol.
259.42K
Volume
192.34K
P/E ratio
46.19
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
In the Last Tech Bust, the S&P 500 Lost Money for a Decade. History Says Stocks With the Highest Yields Gained 5.4% a Year.
Nacionale
·
4 hours ago
Is the S&P 500 in a bear market, and will it rally? No, it's in a correction, 11.6% below its record
Benzinga
·
2 hours ago
Four S&P 500 Stocks Rising in a Falling Market: Pentair, AppLovin, Chipotle, and Gen Digital
BigGo Finance
·
48 minutes ago
AI Boom Cracks, Unleashing US Stock Selloff as S&P 500 and Dow Both Slip Below Correction Line
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd